Olmesartan medoxomil
- Product NDC
- 50090-6632
- 11-digit product format
- 500906632
- Labeler code
- 50090
- Product ID
- 50090-6632_29f0e71a-8c15-458a-9573-d645afd585e0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Olmesartan medoxomil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA204814
- Marketing category
- ANDA
- Marketing start
- 2017-04-25
- Substance
- OLMESARTAN MEDOXOMIL
- Active strength
- 40 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Olmesartan medoxomil
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OLMESARTAN MEDOXOMIL | 40 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6M97XTV3HD |
| Rxcui | 349405 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-6632-0 | Olmesartan medoxomil | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
| 50090-6632-1 | Olmesartan medoxomil | 90 in 1 BOTTLE | TABLET | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-6632 | OLMESARTAN MEDOXOMIL TABLET [A-S MEDICATION SOLUTIONS] | 2 | Current NDC, 2 package rows | 20230912_5f410909-a68a-4ada-963a-32018d37572f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6632-0 | 50090663200 | 30 TABLET in 1 BOTTLE (50090-6632-0) | 30 tablet | 2023-08-25 | No | No | Current |
| 50090-6632-1 | 50090663201 | 90 TABLET in 1 BOTTLE (50090-6632-1) | 90 tablet | 2023-08-25 | No | No | Current |